Author

Melanie Klausner

Johns Hopkins University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Amy Elizabeth DezerniD· 1 shared Bogdan C. Paun· 1 shared Brandy N. Perkins· 1 shared Bum Seok LeeiD· 1 shared Evangeline Watson· 1 shared Gabriel GhiauriD· 1 shared Ivana GojoiD· 1 shared J. David PeskeiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Amy Elizabeth DezernORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A PBD-dimer containing antibody drug conjugate targeting CCRL2 for high-risk MDS/AML

Nour Sabiha Naji, Taha S. Ahmedna, J. David Peske, Xinghan Zeng, Brandy N. Perkins, Zanshé Thompson, Tushar D. Nichakawade, Bum Seok Lee, Evangeline Watson, Theodora Chatzilygeroudi, Li Luo, Bogdan C. Paun, Melanie Klausner, Yuju An, Teodora Supeanu, , Theodoros Karantanos

This paper develops an anti-CCRL2 antibody-drug conjugate (ADC) that shows potent cytotoxicity against high-risk MDS/AML cells without harming healthy hematopoietic cells.

bioRxiv · Aug 17, 2025 · PreprintCancer Biology